Himadri Speciality Chemical Expands Portfolio with New Growth Capex

KOLKATA – Himadri Speciality Chemical Ltd (HSCL) has announced a significant expansion of its manufacturing capabilities, approving capital expenditure (capex) programs totaling over 3.6 billion rupees. The move includes dedicated investments for the production of specialized chemicals and advanced carbon materials, signaling a strategic shift toward high-margin, value-added products.

The board of directors approved 1.28 billion rupees for the establishment of an Anthraquinone and Carbazole manufacturing facility, alongside 1.7 billion rupees dedicated to Super Speciality Carbon Black capacity. Furthermore, the company has earmarked 700 million rupees for a new Carbon Nanotube (CNT) facility in West Bengal. These developments follow a robust financial performance, with the company reporting consolidated revenue from operations of 14.32 billion rupees and a net profit of 2.3 billion rupees for the June 2026 quarter.

Expanding High-Value Chemical Footprint

The investment in Anthraquinone and Carbazole production represents a forward-integration strategy, allowing the company to process its existing coal tar distillates into high-value chemicals. These materials are essential inputs for the dye, pharmaceutical, and electronic industries. By domesticating the production of these compounds, Himadri aims to capture demand in both the Indian market and global segments across Europe, the United States, and Southeast Asia.

Advancing Carbon Material Leadership

The commitment of 1.7 billion rupees toward Super Speciality Carbon Black builds upon the company’s existing status as a global leader in the sector. With its Mahistikry facility in West Bengal already recognized as the world’s largest single-location specialty carbon black plant, this additional capacity is designed to meet the rising demand for performance-driven materials used in plastics, high-end coatings, and advanced ink formulations.

Additionally, the 700 million rupees allocated for a Carbon Nanotube (CNT) facility in West Bengal highlights the company’s intent to lead in next-generation material science. CNTs are increasingly vital for energy storage and advanced battery technologies, a sector where Himadri has been aggressively increasing its footprint.

Financial Performance Overview

The expansion announcements coincide with a period of strong financial growth. For the quarter ended June 30, 2026, Himadri Speciality Chemical Ltd reported consolidated revenue of 14.32 billion rupees and a net profit of 2.3 billion rupees. These figures underscore the company's operational efficiency and its successful execution of a strategy focused on premium product segments.

Official Sources

According to official filings with the BSE Limited and the National Stock Exchange of India Ltd, the board of directors met on July 15, 2026, to review and approve the financial results for the quarter ended June 30, 2026, and to finalize the capital expenditure plans for the upcoming production units.

Why It Matters

These strategic investments are expected to enhance the company’s revenue stability and margin profiles by reducing reliance on commodity products. For investors, the focus on import substitution and global supply chain integration suggests a long-term strategy of value creation. For the industrial sector, the localized manufacturing of Anthraquinone, Carbazole, and CNTs provides a more reliable domestic supply chain for critical chemical inputs.

Key Facts at a Glance

• Total Capex Approved: 3.68 billion rupees across three major projects.

• New Product Lines: Dedicated facilities for Anthraquinone, Carbazole, and Carbon Nanotubes.

• Operational Scale: Strengthening of the Mahistikry facility, which serves as a global hub for specialty carbon black production.

• Financials: The company reported June quarter consolidated revenue of 14.32 billion rupees and a net profit of 2.3 billion rupees.

FAQ

What are the primary products targeted by the new capex? The capex focuses on Anthraquinone, Carbazole, Super Speciality Carbon Black, and Carbon Nanotubes (CNT).

Where will the new facilities be located? The company is leveraging its existing manufacturing footprint in West Bengal for these expansions.

How is the expansion being funded? The company has indicated that its expansion strategies are largely supported by internal accruals and strong cash flow generation.

What is the strategic importance of Anthraquinone and Carbazole? These chemicals are critical for high-value applications in the pharmaceutical, dye, and electronics sectors, allowing the company to enter niche, high-margin markets.

Source: BSE Limited, National Stock Exchange of India Ltd, and company disclosures.